Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries.
Sven StreitMarjolein VerschoorNicolas RodondiDaiana BonfimRobert A BurmanClaire CollinsGerasimovska Kitanovska BiljanaSandra GintereRaquel Gómez BravoKathryn HoffmannClaudia IftodeKasper L JohansenNgaire KerseTuomas H KoskelaSanda Kreitmayer PeštićDonata KurpasChristian D MallenHubert MaisoneuveChristoph MerloYolanda MuellerChristiane MuthMarija Petek ŠterFerdinando PetrazzuoliThomas RosemannMartin SattlerZuzana ŠvadlenkováAthina TatsioniHans ThulesiusVictoria TkachenkoPeter TorzsaRosy TsopraTuz CananRita P A ViegasShlomo VinkerMargot W M de WaalAndreas ZellerJacobijn GusseklooRosalinde K E PoortvlietPublished in: BMC geriatrics (2017)
Across countries, we found considerable variation in starting antihypertensive medication in oldest-old. The frail oldest-old had an odds ratio of 0.53 of receiving antihypertensive treatment. Future hypertension trials should also include frail patients to acquire evidence on the efficacy of antihypertensive treatment in oldest-old patients with frailty, with the aim to get evidence-based data for clinical decision-making.